Validity of the 12-item French version of the Tobacco Craving Questionnaire in treatment-seeking smokers

Berlin, Ivan; Singleton, Edward G.; Heishman, Stephen J.

doi:10.1093/ntr/ntq039

Cited by 57 publications

(43 citation statements)

References 42 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The FTCQ-12 and MNWS have established construct validity in French smokers. 27,29 In the current investigation, Cronbach's alpha for the general craving score and total withdrawal score was respectively, 0.74 and 0.77. Craving and withdrawal are ordinarily most prominent during the first 2 weeks of quitting 30 ; thus, we evaluated the incidence of smoking 2 weeks after the quit date (abstinent = 0, smoking = 1), which was verified by breath carbon monoxide (≤ 8 parts per million; Smokeanalyzer, Bedfont Scientific Ltd, Rochester, Kent, United Kingdom).…”

Section: Methodsmentioning

confidence: 46%

“…6 Conceivably, the modest correlations between MNWS withdrawal might be attributable to general symptoms of unease (eg, sadness/anxiety) as opposed to nicotine withdrawal. Nevertheless, FTCQ-12 craving and MNWS withdrawal are also strongly correlated at baseline in treatment seekers, 27 and pregnant smokers have elevated levels of craving and withdrawal prior to smoking cessation. 47,48 As stated by the Society for Research on Nicotine and Tobacco (SRNT) Subcommittee on Biochemical Verification of tobacco use and cessation, "cotinine appears to be the best marker to gauge the severity of dependence".…”

Section: Discussionmentioning

confidence: 98%

“…6 Also included were smoking-related characteristics indicative of dependence including single-item measures: salivary cotinine concentration, current number of cigarettes smoked per day (CPD), number of previous quit attempts, and age of regular smoking initiation. We assessed simultaneously French versions of the Tobacco Craving Questionnaire (FTCQ-12) 27 to assess craving and the Minnesota Nicotine Withdrawal Scale (MNWS) 28 to evaluate withdrawal. The 12 items on the FTCQ-12 and the eight items on the MNWS were each summed to yield a general craving score and a total withdrawal score, respectively.…”

Section: Methodsmentioning

confidence: 99%

See 2 more Smart Citations

A Comparison of the Fagerström Test for Cigarette Dependence and Cigarette Dependence Scale in a Treatment-Seeking Sample of Pregnant Smokers

Berlin¹,

Singleton²,

Heishman³

2015

NICTOB

View full text Add to dashboard Cite

Known previously as the Fagerström Tolerance Questionnaire 2 and Fagerström Test for Nicotine Dependence 3,4 the six-item FTCD is the most widely-used, brief measure of cigarette dependence. 5 The five-item Cigarette Dependence Scale 6 is also a brief and valid measure of cigarette dependence. The CDS-5 has psychometric properties similar to its parent measure, the CDS-12, but with less comprehensive content in terms of tapping compulsion, withdrawal symptoms, loss of control, time allocation, neglect of other activities, and persistence in smoking despite harm.Results of direct comparisons between the FTCD and the CDS have been mixed, with the vast majority of studies involving contrasts between the FTCD and CDS-12. In general, the FTCD and CDS-12 are moderately associated with each other and both are correlated positively with cigarettes per day and age at first daily smoking, 6-8 yet neither measure is associated significantly with the Methods:This was a secondary analysis of data of pregnant smokers (N = 476) enrolled in a smoking cessation study. We assessed internal consistency, reliability, and examined correlations between the instruments and smoking-related behaviors for construct validity. We evaluated predictive validity by testing how well the measures predict abstinence 2 weeks after quit date. Results: Cronbach's alpha coefficient for the CDS-5 was 0.62 and for the FTCD 0.55. Measures were strongly correlated with each other, although FTCD, but not CDS-5, was associated with saliva cotinine concentration. The FTCD, CDS-5, craving to smoke, and withdrawal symptoms failed to predict smoking status 2 weeks following the quit date. Conclusions: Suboptimal reliability estimates and failure to predict short-term smoking call into question the value of including either of the brief measures in studies that aim to explain the obstacles to smoking cessation during pregnancy.

show abstract

Section: Methodsmentioning

confidence: 46%

Section: Discussionmentioning

confidence: 98%

Section: Methodsmentioning

confidence: 99%

See 1 more Smart Citation

A Comparison of the Fagerström Test for Cigarette Dependence and Cigarette Dependence Scale in a Treatment-Seeking Sample of Pregnant Smokers

Berlin¹,

Singleton²,

Heishman³

2015

NICTOB

View full text Add to dashboard Cite

show abstract

“…Both studies were approved by the Ethics Committee of the Pitié-Salpêtrière Hospital, Paris, France. (Berlin et al, 2010) and the French version of the Minnesota Nicotine Withdrawal Scale (MNWS; Hughes andHatsukami, 1986, 1998). The FTCQ-12 is a valid and reliable 12-item self-report instrument that assesses four dimensions of tobacco craving (Factors 1-4: Emotionality, Expectancy, Compulsivity, Purposefulness).…”

Section: Confirmatory Datasetmentioning

confidence: 99%

“…Abbreviated versions exist [e. g., the 10-item Questionnaire of Smoking Urges (QSU-brief; Cox et al, 2001) and 12-item Tobacco Craving Questionnaire (TCQ-12;Heishman et al, 2008)], but the methodological complexity of multifactorial scales often yields a complicated interpretation of the clinical To facilitate translational research for relapse prevention in smoking cessation, we have developed an in-treatment screening procedure based on weekly craving assessments of a general sample of male and female French smokers (Berlin et al, 2013). This research demonstrated that a risk score (RS) derived from the brief French Tobacco Craving Questionnaire (FTCQ-12; Berlin et al, 2010) Factor 2 (Expectancy) plus Factor 4 (Purposefulness) was a robust predictor of smoking within 1-8 weeks after enrollment in a smoking cessation trial using nicotine replacement therapy (NRT). The FTCQ-12 RS was a better predictor than the single craving item assessed using a French translation of the Minnesota Nicotine Withdrawal Scale (MNWS; Hughes andHatsukami, 1986, 1998), whereas MNWS craving was a better predictor of abstinence.…”

Section: Introductionmentioning

confidence: 99%

Cross validation of the prognostic and diagnostic utility of tobacco craving in a general and a pregnant sample of treatment-seeking smokers

Berlin¹,

Singleton²,

Heishman³

2015

Drug and Alcohol Dependence

View full text Add to dashboard Cite

Nicotine replacement therapy for smoking cessation

Stead

Perera

Bullen

et al. 2012

Cochrane Database of Systematic Reviews

1,150

496

View full text Add to dashboard Cite

BackgroundThe aim of nicotine replacement therapy (NRT) is to temporarily replace much of the nicotine from cigarettes to reduce motivation to smoke and nicotine withdrawal symptoms, thus easing the transition from cigarette smoking to complete abstinence. ObjectivesThe aims of this review were:To determine the effect of NRT compared to placebo in aiding smoking cessation, and to consider whether there is a difference in effect for the different forms of NRT (chewing gum, transdermal patches, oral and nasal sprays, inhalers and tablets/lozenges) in achieving abstinence from cigarettes.To determine whether the effect is influenced by the dosage, form and timing of use of NRT; the intensity of additional advice and support offered to the smoker; or the clinical setting in which the smoker is recruited and treated.To determine whether combinations of NRT are more likely to lead to successful quitting than one type alone.To determine whether NRT is more or less likely to lead to successful quitting compared to other pharmacotherapies. Search methodsWe searched the Cochrane Tobacco Addiction Group trials register for papers mentioning 'NRT' or any type of nicotine replacement therapy in the title, abstract or keywords. Date of most recent search July 2012. Selection criteriaRandomized trials in which NRT was compared to placebo or to no treatment, or where different doses of NRT were compared. We excluded trials which did not report cessation rates, and those with follow-up of less than six months. Data collection and analysisWe extracted data in duplicate on the type of participants, the dose, duration and form of nicotine therapy, the outcome measures, method of randomization, and completeness of follow-up.The main outcome measure was abstinence from smoking after at least six months of follow-up. We used the most rigorous definition of abstinence for each trial, and biochemically validated rates if available. We calculated the risk ratio (RR) for each study. Where appropriate, we performed meta-analysis using a Mantel-Haenszel fixed-effect model.

show abstract

Validity of the 12-item French version of the Tobacco Craving Questionnaire in treatment-seeking smokers

Cited by 57 publications

References 42 publications

A Comparison of the Fagerström Test for Cigarette Dependence and Cigarette Dependence Scale in a Treatment-Seeking Sample of Pregnant Smokers

A Comparison of the Fagerström Test for Cigarette Dependence and Cigarette Dependence Scale in a Treatment-Seeking Sample of Pregnant Smokers

Cross validation of the prognostic and diagnostic utility of tobacco craving in a general and a pregnant sample of treatment-seeking smokers

Nicotine replacement therapy for smoking cessation

Contact Info

Product

Resources

About